FCM
RVMD icon

Fieldview Capital Management’s Revolution Medicines RVMD Stock Holding History

Fieldview Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$314K Buy
+1,531
New +$303K 0.09% 397
2026
Q2 		– Sell
-2,582
Closed -$251K – 684
2026
Q1 		$251K Buy
+2,582
New +$261K 0.07% 402

Other funds holding RVMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return

Fieldview Capital Management's RVMD Position: Q3 2026 in Review

Fieldview Capital Management opened a new position in Revolution Medicines (RVMD) in Q3 2026: 1,531 shares worth $314K. The stake represents 0.09% of the portfolio and ranks #397 among its holdings. This is a return to the name: Fieldview Capital Management previously reported a position in RVMD as recently as Q1 2026.

Fieldview Capital Management first reported a position in RVMD in Q1 2026 and has held it in 2 quarters since. 577 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Fieldview Capital Management held 1,531 shares of Revolution Medicines worth $314K as of Q3 2026.
  • Revolution Medicines was a new Fieldview Capital Management position in Q3 2026.
  • Revolution Medicines made up 0.09% of Fieldview Capital Management's portfolio in Q3 2026, its #397 holding.
  • Fieldview Capital Management first reported a position in Revolution Medicines in Q1 2026 and has held it in 2 quarters since.
  • 577 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Fieldview Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.